147 related articles for article (PubMed ID: 1766672)
1. High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif.
Fisher RJ; Mavrothalassitis G; Kondoh A; Papas TS
Oncogene; 1991 Dec; 6(12):2249-54. PubMed ID: 1766672
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
3. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
4. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
Chen JH; Wright CD
Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
[TBL] [Abstract][Full Text] [Related]
5. Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding.
Fisher RJ; Koizumi S; Kondoh A; Mariano JM; Mavrothalassitis G; Bhat NK; Papas TS
J Biol Chem; 1992 Sep; 267(25):17957-65. PubMed ID: 1517230
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
[TBL] [Abstract][Full Text] [Related]
7. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
8. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
9. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
[TBL] [Abstract][Full Text] [Related]
10. Ets up-regulates MET transcription.
Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
[TBL] [Abstract][Full Text] [Related]
11. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.
Schmidt M; Schmidt AM; Dietl J; Kammerer U
Oncol Rep; 2007 Aug; 18(2):457-63. PubMed ID: 17611671
[TBL] [Abstract][Full Text] [Related]
13. The biology of the Ets1 proto-oncogene.
Dittmer J
Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
[TBL] [Abstract][Full Text] [Related]
14. Sequence specific binding of the transcription factor c-Ets1 to the human immunodeficiency virus type I long terminal repeat.
Holzmeister J; Ludewig B; Pauli G; Simon D
Biochem Biophys Res Commun; 1993 Dec; 197(3):1229-33. PubMed ID: 8280137
[TBL] [Abstract][Full Text] [Related]
15. Negative regulatory elements in the human ETS1 gene promoter.
Chen JH; Jeha S; Oka T
Oncogene; 1993 Jan; 8(1):133-9. PubMed ID: 8423991
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
[TBL] [Abstract][Full Text] [Related]
17. Serum response factor associated ETS proteins: ternary complex factors and PEA3-binding factor.
Liu SH; Ng SY
Biochem Biophys Res Commun; 1994 Jun; 201(3):1406-13. PubMed ID: 8024585
[TBL] [Abstract][Full Text] [Related]
18. c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.
Leprince D; Crepieux P; Stehelin D
Oncogene; 1992 Jan; 7(1):9-17. PubMed ID: 1741168
[TBL] [Abstract][Full Text] [Related]
19. Sequence specific binding of Ets-1 to the mouse cytokeratin EndoA gene enhancer.
Hamazato F; Fujimura Y; Tamai Y; Takemoto Y; Matsushiro A; Nozaki M
Biochem Biophys Res Commun; 1993 Apr; 192(2):430-8. PubMed ID: 7683460
[TBL] [Abstract][Full Text] [Related]
20. Binding of ETS family members is important for the function of the c-sis/platelet-derived growth factor-B TATA neighboring sequence in 12-O-tetradecanoylphorbol-13-acetate-treated K562 cells.
Kujoth GC; Robinson DF; Fahl WE
Cell Growth Differ; 1998 Jul; 9(7):523-34. PubMed ID: 9690620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
